Aurora RH Collagen (1 x 2.5ml)

Aurora

Skin Booster

Injectable collagen skin booster

Distributed by a UK aesthetics wholesaler stating that all products are CE or CPNP approved where appropriate

Distributed by a UK aesthetics wholesaler stating that all products are CE or CPNP approved where appropriate

Injectable collagen skin booster

Description

Aurora RH Collagen is an injectable, medical-grade skin booster containing high-purity recombinant human collagen (Type I and Type III) combined with dual-weight hyaluronic acid. It is designed to restore facial volume, improve skin elasticity, reduce wrinkles and rejuvenate the skin while providing deep hydration and natural-looking results. The product is supplied as a 2.5 ml prefilled syringe intended for injection into the upper to mid dermis by trained healthcare professionals.

Bnefits

Improves skin elasticity and firmness
Reduces the appearance of fine lines and wrinkles
Restores volume and supports facial contouring
Promotes long-term collagen and elastin regeneration
Deeply hydrates the skin via dual hyaluronic acid complex
Provides natural-looking, smooth integration into the skin
High-purity, bioengineered recombinant human collagen identical to human collagen
100% animal-free, reducing risk of allergic reactions to animal-derived collagen
High biocompatibility and reduced allergenicity
Supports skin rejuvenation and overall skin quality

Indications

Facial contouring
Wrinkle reduction
Skin rejuvenation and dermal quality improvement
Soft tissue augmentation
Treatment of volume loss in the face
Improvement of skin elasticity and hydration

Composition

Recombinant Human Collagen (RHC) 20 mg (Type I 10 mg + Type III 10 mg) per 2.5 ml
Hyaluronic Acid 50 mg total per 2.5 ml (Low molecular weight HA 25 mg + High molecular weight HA 25 mg)
Non–cross-linked hyaluronic acid
Recombinant human collagen produced via controlled, ethical fermentation process (E. coli expression and purification)
Bioengineered, animal-free collagen identical to human collagen

Formulation

Injectable gel skin booster
Recombinant human Type I and Type III collagen in combination with dual-weight hyaluronic acid
Non–cross-linked HA for volume restoration and deep hydration
Supplied sterile in a prefilled syringe for intradermal injection

Packaging

1 x 2.5 ml prefilled sterile syringe per box
Box labelled as Aurora RH Collagen
Shelf life: 36 months from manufacture (as per brochure)

Usage

For professional use only and to be administered by trained healthcare professionals.
Recommended injection depth: upper to mid dermis (approximately 1.0–2.0 mm), injecting directly into the dermal layer beneath the epidermis.
Recommended injection volume: approximately 0.01–0.03 ml per injection point, following an appropriate injection pattern according to the treatment area.
Recommended needle: 31G or 32G needle with a length of 4 mm or 6 mm.
Treatment protocol: generally 3 to 5 treatment sessions performed at 2–3 week intervals for optimal and stable results.
Maintenance protocol: a booster session is recommended approximately every 3 months after the initial course.
Before the procedure, check the treatment area carefully for any skin damage, inflammation, active acne, dermatitis or infectious skin disease.
Strictly adhere to disinfection steps before and after the procedure to minimise risk of infection.
For 24 hours after treatment, patients should avoid saunas, strenuous exercise and alcohol consumption.
Always check for any known allergies to topical anaesthetics or product ingredients before treatment.

Contraindications

Pregnancy
Breastfeeding
Known keloid predisposition
Active acne in the treatment area
Dermatitis or inflammatory skin disease in the treatment area
Infectious or open skin lesions in the treatment area
Recent skin procedures in the area (treatment should be avoided immediately after other skin procedures and within approximately 1 week of laser treatments or chemical peels)
Known or suspected allergy to any of the product ingredients or to topical anaesthetics used in conjunction with treatment

Adverse Effects

Not publicly listed

Storage Conditions

Not publicly listed

Duration

Initial protocol typically consists of 3\u20135 sessions performed every 2\u20133 weeks, followed by maintenance treatments approximately every 3 months to sustain results.